Thalys Medical Technology Group (SHSE:603716) FCF Margin % : 9.16% (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Thalys Medical Technology Group's Free Cash Flow for the three months ended in Sep. 2024 was ¥41 Mil. Thalys Medical Technology Group's Revenue for the three months ended in Sep. 2024 was ¥444 Mil. Therefore, Thalys Medical Technology Group's FCF Margin % for the quarter that ended in Sep. 2024 was 9.16%.

As of today, Thalys Medical Technology Group's current FCF Yield % is -0.39%.

The historical rank and industry rank for Thalys Medical Technology Group's FCF Margin % or its related term are showing as below:

SHSE:603716' s FCF Margin % Range Over the Past 10 Years
Min: -19.47 Med: -3.35 Max: 4.24
Current: -0.4

During the past 13 years, the highest FCF Margin % of Thalys Medical Technology Group was 4.24%. The lowest was -19.47%. And the median was -3.35%.

SHSE:603716's FCF Margin % is ranked better than
52.83% of 212 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.335 vs SHSE:603716: -0.40

Thalys Medical Technology Group FCF Margin % Historical Data

The historical data trend for Thalys Medical Technology Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group FCF Margin % Chart

Thalys Medical Technology Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-0.14

-5.54

-7.45

-1.15

4.24

Thalys Medical Technology Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial															-5.11	1.19	-6.37	-4.71	9.16

Competitive Comparison of Thalys Medical Technology Group's FCF Margin %

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thalys Medical Technology Group's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Thalys Medical Technology Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Thalys Medical Technology Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	85.061	/	2006.134
	=	4.24 %

Thalys Medical Technology Group's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	40.716	/	444.424
	=	9.16 %

Thalys Medical Technology Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Thalys Medical Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040

Website

https://www.thalys.net.cn

Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.

Executives

Wang Jun Ming	senior management
Wang Zheng	senior management
Wang Wen Bin	senior management
Liu Wen Hao	Director
Huang Yong Xi	senior management
Lei Xian Kun	Director
Fan Li	Director
Liu Yuan	senior management
Wan Li Bo	senior management
Wen Wei	Director
Chou Jian	senior management
Song Yu	Director

Thalys Medical Technology Group Headlines

No Headlines